Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cardiac remodeling interrupted, reversed by sildenafil

Jan. 26, 2005

Sorin completes enrollment in JUPITER II study of Janus Carbostent

Jan. 26, 2005

New phase III and II data for SPP-100 for hypertension

Jan. 25, 2005

Researchers at Leiden University synthesize a novel ENT1 inhibitor

Jan. 24, 2005

Novartis grants Meda European rights to Cibacen and Cibadrex

Jan. 24, 2005

IRAK1 shows promise as a novel target in the treatment of atherosclerosis

Jan. 21, 2005

TAK-242 shows promise in the treatment of sepsis

Jan. 20, 2005

Zoniporide reported to induce protective effects after resuscitation from ventricular fibrillation

Jan. 20, 2005

Taxus Liberte paclitaxel-eluting coronary stent launched in 18 countries

Jan. 20, 2005

CKD-712 is a promising agent for the treatment of sepsis

Jan. 20, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....